Clinical trial · Interventional
JING SI HERBAL TEA and Urinary Tract Symptoms in Bladder Cancer
JING SI HERBAL TEA in the Treatment of Lower Urinary Tract Symptoms After Intravesical Therapy in Patients With Bladder Cancer
NCT05739071CI-TRIAL-00094963enrolling by invitationN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To identify the effects of JING SI HERBAL TEA in the treatment of lower urinary tract symptoms after intravesical therapy in patients with bladder cancer.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Bladder Cancer | Malignant Bladder Neoplasm | CURATED_EXACT | 0.92 |
| Herbal Interaction | — | UNRESOLVED | — |
| Intravenous Drug Usage | — | UNRESOLVED | — |
| Lower Urinary Tract Symptoms | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| JING SI HERBAL TEA | Dietary Supplement | — | UNRESOLVED |
| Placebo | Dietary Supplement | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Experimental (group 1)
- description
- This group will receive two sachets of JING SI HERBAL TEA a day (one in the morning and one in the evening).
- interventionNames
- Dietary Supplement: JING SI HERBAL TEA
- type
- PLACEBO_COMPARATOR
- label
- Control (group 2)
- description
- This group will receive two sachets of placebo a day (same way as group 1).
- interventionNames
- Dietary Supplement: Placebo
Primary outcomes (1)
- measure
- Urinary symptoms
- timeFrame
- The outcome evaluation will be at the following time points: 1 week, 2 weeks, 3 weeks, 4 weeks, 5 weeks and 6 weeks
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
- Maximum age
- 100 Years
Show eligibility criteria text
Inclusion Criteria: * Clinical diagnosis bladder cancer * Under intravesical installation therapy Exclusion Criteria: * Patients under 20 years old or greater than 100 years old * Women with pregnancy or breastfeeding plans * Bladder cancer are being treated in another hospital * Had admitted due to other disease in the past 3 months * Unable to understand the questionnaire
References
Publications (0)
Data not yet available
No reference posted for this study.